Nebenwirkungen · Xeplion
Xeplion 150 mg and Xeplion 100 mg prolonged release suspension for injection · Abschnitt 4.8 · PDF-Seite 31
HOS-124292 · Präparat HOS-095825
System Organ Adverse reactions Class Frequency Very Common Uncommon Rare Not knowna common Infections and upper respiratory pneumonia, eye infection, infestations tract infection, bronchitis, respiratory acarodermatitis urinary tract tract infection, infection, influenza sinusitis, cystitis, ear infection, tonsillitis, onychomycosis, cellulitis, subcutaneous abscess Blood and white blood cell count neutropenia, agranulocytosis lymphatic system decreased, anaemia thrombocytopenia disorders , eosinophil count increased Immune system hypersensitivity anaphylactic disorders reaction Endocrine hyperprolactinaemia inappropriate b disorders antidiuretic hormone secretion, glucose urine present Metabolism and hyperglycaemia, diabetes mellitusd, diabetic water nutrition weight increased, hyperinsulinaemia, ketoacidosis, intoxication disorders weight decreased, increased appetite, hypoglycaemia, decreased appetite anorexia, blood polydipsia triglycerides increased, blood cholesterol increased Psychiatric insomniae agitation, sleep disorder, mania, catatonia, sleep-related disorders depression, anxiety libido decreased, confusional state, eating disorder nervousness, somnambulism, nightmare blunted affect, anorgasmia Nervous system parkinsonismc, tardive dyskinesia, neuroleptic diabetic coma disorders akathisiac, syncope, malignant sedation/somnolence psychomotor syndrome, , dystoniac, hyperactivity, cerebral dizziness, dizziness postural, ischaemia, dyskinesiac, tremor, disturbance in unresponsive to headache attention, dysarthria, stimuli, loss of dysgeusia, consciousness, hypoaesthesia, depressed level of paraesthesia consciousness, convulsione, balance disorder, coordination abnormal, head titubation Eye disorders vision blurred, glaucoma, eye floppy iris conjunctivitis, dry eye movement syndrome disorder, eye (intraoperative) rolling, photophobia, lacrimation increased, ocular hyperaemia Ear and vertigo, tinnitus, ear labyrinth pain disorders
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-06-03T17:43:00Z · SHA-256 2d38bdc767adb9ede103df61263cd780b613b64f4605afd38720f25f2e234f90 · Passage be9432dddd60cf031d814839bac1dbed8ed9a833c993595ab245a770b1b9713f · Zeichen 976–6577 im Abschnitt